日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cell-free secretome of CD56(bright)CD16(bright) directly reprogrammed NK cells enhances wound healing via CCL3/4/5-CCR5 signaling.

CD56(bright)CD16(bright)直接重编程NK细胞的无细胞分泌组通过CCL3/4/5-CCR5信号通路增强伤口愈合。

Aging-induced decrease in progenitor B cells enhances the osteoclastogenesis of bone marrow macrophages via ROS-activated Fos/CCL3 signaling‌ pathway

衰老引起的B细胞祖细胞减少通过ROS激活的Fos/CCL3信号通路增强骨髓巨噬细胞的破骨细胞生成。

Sun, Ruiqing; Luo, Lan; Chen, Yang; Sun, Liangjie; Huo, Yuhao; Ding, Chong; Wang, Yixiang

Serum Chemokines CCL3 and CCL7 as Complementary Diagnostic Biomarkers Across Tumor Grades in Clear Cell Renal Cell Carcinoma

血清趋化因子CCL3和CCL7作为透明细胞肾细胞癌不同肿瘤分级的互补诊断生物标志物

Sokólska, Weronika; Zajkowska, Monika; Kulczyńska-Przybik, Agnieszka; Werel, Tadeusz; Orywal, Karolina

POSTN⁺ cancer-associated fibroblast-CCL3⁺ macrophage crosstalk defines the immune-excluded tumor microenvironment in clear cell renal cell carcinoma

POSTN⁺癌相关成纤维细胞-CCL3⁺巨噬细胞相互作用定义了透明细胞肾细胞癌中免疫排斥的肿瘤微环境。

Wang, Yingjian; Yue, Bingtong; Ni, Hongqiang; Chen, Jinchun; Shi, Run; Wang, Zhe; Dai, Xinglai; Sheng, Maolin

Prognostic Significance and Immune Correlation of CCL3 Expression in Colon Adenocarcinoma: Insights From Multidatabase Analysis

CCL3表达在结肠腺癌中的预后意义和免疫相关性:来自多数据库分析的启示

Kumar, Vikrant; Khan, Nawaid Hussain; Kumar, Shashi Nandar; Mahajan, Neeraj; Aziz, Wafa; Kumar, Vinay; Verma, Chaitenya

Rosuvastatin in Combination With Bortezomib Promotes Osteogenesis in Myeloma Bone Disease by Inhibiting the Secretion of CCL3

瑞舒伐他汀联合硼替佐米通过抑制CCL3的分泌促进骨髓瘤骨病中的骨生成

Qu, Fujun; Hui, Mingxu; Yang, Fan; Huang, Bo; Liu, Nian; He, Yuchan; Wang, Xiaotao

Loss of TACC2 impairs chemokine CCL3 and CCL4 expression and reduces response to anti-PD-1 therapy in soft tissue sarcoma

TACC2 的缺失会损害趋化因子 CCL3 和 CCL4 的表达,并降低软组织肉瘤对 PD-1 抑制剂治疗的反应。

Jing Yang # ,Xiuxia Lu # ,Qiyan Cai # ,Mengmeng Liu # ,Tianliang Xia ,Dongchun Hong ,Liyuan Le ,Xinke Zhang ,Xing Zhang

Hyperglycemia induces an immunosuppressive microenvironment in colorectal cancer liver metastases by recruiting peripheral blood monocytes through the CCL3-CCR1 axis

高血糖通过CCL3-CCR1轴募集外周血单核细胞,在结直肠癌肝转移灶中诱导免疫抑制性微环境。

Peng, Han; Pan, Yuwei; Sun, Yixin; Wang, Xuesong; Fan, Xue; Wang, Yajuan; Zhao, Lintao; Li, Xi; Dong, Yan; Chen, Jianfang; Zhou, Jie; Du, Yun; Yu, Qing; Yang, Yongtao; Zhang, Yue; Li, Jianjun; Liang, Houjie; Huang, Shuo

Targeted delivery of CCL3 reprograms macrophage antigen presentation and enhances the efficacy of immune checkpoint blockade therapy in hepatocellular carcinoma

靶向递送CCL3可重编程巨噬细胞抗原呈递,并增强免疫检查点阻断疗法在肝细胞癌中的疗效。

Liu, Muqi; Li, Linzhe; Cao, Lu; Li, Wei; Gu, Xingshi; Yang, Min; Wu, Di; Li, Yanan; Deng, Yao; Zhang, Juan; Yang, Cejun; Liang, Qi; Liu, Huaping; Rong, Pengfei; Ma, Xiaoqian; Wang, Wei

MAVS/CMTM6 axis couples mitochondrial homeostasis to immunogenic senescence via CCL3-driven T-cell recruitment in renal carcinoma

在肾癌中,MAVS/CMTM6轴通过CCL3驱动的T细胞募集将线粒体稳态与免疫原性衰老联系起来。

Wang, Hanfeng; Fan, Yang; Liang, Qiyang; Tao, Wen; Chen, Xinran; Wang, Jichen; Cao, Senming; Ye, Jiali; Zuo, Shidong; Zhang, Chi; Shen, Donglai; Gao, Yu; Huang, Qingbo; Ma, Xin; Zhang, Xu; Huang, Yan; Yang, Minghui